Protagenic Therapeutics (PTIX) Exec Chair Armen Garo Buys 2,700 Shares

What Happened
Armen Garo H, Executive Chair and Principal Officer (also a director) of Protagenic Therapeutics, purchased 2,700 shares on 2026-08-19 at $0.35 per share, for a total reported acquisition cost of $945. This was reported on a Form 4 filed 2026-08-20. As a purchase (transaction code P), the trade represents an insider buy rather than a sale.

Key Details

• Transaction date: 2026-08-19; filing date: 2026-08-20 (appears timely).
• Price per share: $0.35; shares acquired: 2,700; total value: $945.
• Transaction type: Open market or private purchase (code P).
• Shares owned after the transaction: not specified in the reported Form 4.
• No 10b5-1 plan, tax-withholding, or other footnotes were referenced in the filing.

Context
Small-dollar insider purchases like this are factual signals of an insider buying stock, but the amount ($945) is modest. Retail investors should note the purchase but consider it alongside other filings, company fundamentals, and market factors before drawing conclusions.